UNSPSC 51281630: Astromicin

This classification denotes an aminoglycoside antibiotic with the molecular formula C17H35N5O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7JHD84H15J, chemically known as 2-amino-N-[(1S,2R,3R,4S,5S,6R)-4-amino-3-[(2R,3R,6S)-3-amino-6-(1-aminoethyl)tetrahydropyran-2-yl]oxy-2,5-dihydroxy-6-methoxy-cyclohexyl]-N-methyl-acetamide but generally known as astromicin, which bears US NIH Compound Identifier 65345.

UNSPSC 51281630 Astromicin is a Commodity code that state and local governments use to classify pharmaceutical products, though recent solicitation activity under this code shows a broader pattern of health system procurement spanning naloxone, emergency medical supplies, and generic pharmaceuticals rather than astromicin specifically. State and local issuing bodies procuring under this code include county health departments, city fire departments, state health and human services agencies, and multistate cooperative purchasing alliances serving both traditional government jurisdictions and healthcare facilities. The work being solicited reflects practical emergency response and pharmacy benefit management needs: Seminole County, Florida is procuring naloxone and drug deactivation systems for community health delivery; the City of Tampa's Fire Department Rescue Division is acquiring medical and first aid consumables including respiratory equipment, cardiac monitoring devices, and bandaging materials; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) is establishing statewide contracts for generic pharmaceuticals and over-the-counter products distributed through authorized wholesalers to participating state and local facilities, including Oregon.

Recent activity concentrates in Florida, Texas, and Minnesota, with the most substantial procurement volume under the MMCAP RFP for generic pharmaceuticals and OTC products, due March 26, 2026, which requires vendors to supply through three authorized wholesalers and maintain specific insurance and FDA compliance certifications. The City of Tampa issued an IFB (Bid Number 26-P-00145) for medical and first aid supplies due March 13, 2026, with an estimated contract value of $700,000 and a small local business enterprise set-aside; the procurement specifies 169 line items and a one-year award period with two optional one-year renewals. Seminole County's IFB 60459723LAS, posted June 30, 2026, seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building and a response deadline of July 26, 2023. Texas HHS Commission issued an RFI (HHS0017013) in April 2026 as preliminary market intelligence for a direct-to-manufacturer prescription program serving self-insured employee health plans and state agencies, with responses due April 3, 2026, signaling upstream procurement planning rather than immediate contract opportunity.